Shionogi & Co., Ltd. (OTCMKTS:SGIOY – Get Free Report) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totalling 400 shares, a decline of 86.2% from the June 30th total of 2,900 shares. Based on an average daily volume of 356,700 shares, the short-interest ratio is currently 0.0 days.
Shionogi & Co., Ltd. Price Performance
OTCMKTS SGIOY traded up $0.11 during trading hours on Thursday, hitting $10.82. 152,478 shares of the company’s stock traded hands, compared to its average volume of 115,803. Shionogi & Co., Ltd. has a 52-week low of $9.33 and a 52-week high of $13.67. The company has a market capitalization of $12.83 billion, a PE ratio of 11.15, a PEG ratio of 3.07 and a beta of 0.21. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.86 and a quick ratio of 5.37. The firm’s 50-day moving average is $10.31 and its 200-day moving average is $11.55.
Shionogi & Co., Ltd. (OTCMKTS:SGIOY – Get Free Report) last announced its quarterly earnings data on Monday, May 13th. The company reported $0.21 earnings per share (EPS) for the quarter. Shionogi & Co., Ltd. had a net margin of 37.29% and a return on equity of 13.20%. The company had revenue of $662.08 million during the quarter. Equities analysts forecast that Shionogi & Co., Ltd. will post 0.87 EPS for the current fiscal year.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Read More
- Five stocks we like better than Shionogi & Co., Ltd.
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- 3 Fintech Stocks With Good 2021 Prospects
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Which Wall Street Analysts are the Most Accurate?
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.